Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China-Reference-Cited by-同舟云学术

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

Published:2020-03 Issue:2 Volume:22 Page:74-79
ISSN:1286-4579
Container-title:Microbes and Infection
language:en
Short-container-title:Microbes and Infection

Author:

Yu Fei,Du Lanying,Ojcius David M.,Pan Chungen,Jiang Shibo

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Microbiology

Reference78 articles.

1. Cross-reactive antibodies in convalescent SARS patients’ sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests;Chan;J Infect,2013

2. Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012;Aburizaiza;J Infect Dis,2014

3. Specific serology for emerging human coronaviruses by protein microarray;Reusken;Euro Surveill,2013

4. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV;Zhao;Virol J,2013

5. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle;Lu;J Med Virol,2020

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study;Virology Journal;2024-09-09

2. Monitoramento pós-mercado dos testes rápidos para detecção de anticorpos da COVID-19: análise de dados da plataforma Microsoft® Power Bi;Vigilância Sanitária em Debate;2024-06-28

3. The Neurological Implications of COVID-19: A Comprehensive Narrative Review;Cureus;2024-05-15

4. A comparative analysis of TCR immune repertoire in COVID-19 patients;Human Immunology;2024-05

5. The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review;Planta Medica;2023-11-13